Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Barrett Esophagus 12Stomach Neoplasms 6Adenocarcinoma Of Esophagus 6Gastroesophageal Reflux 4Gastritis, Atrophic 2Esophageal Neoplasms 2Weight Loss 1Thrombocythemia, Essential 1Stomach Ulcer 1Primary Myelofibrosis 1Precancerous Conditions 1Polycythemia Vera 1Pancreatic Neoplasms 1Neoplasms 1Myeloproliferative Disorders 1Lymphoma, Mantle-Cell 1Gastrointestinal Neoplasms 1Gastrointestinal Hemorrhage 1Gastrointestinal Diseases 1Gastritis 1Esophagitis 1Esophageal Squamous Cell Carcinoma 1Deglutition Disorders 1Colorectal Neoplasms 1Cholangiocarcinoma 1Carcinoma, Hepatocellular 1Adenomatous Polyposis Coli 1Adenocarcinoma of the Esophagogastric Junction 1

Interventions

Gemcitabine 112Cisplatin 76Oxaliplatin 44pembrolizumab 34Fluorouracil 32Capecitabine 30durvalumab 27Leucovorin 26lenvatinib 23Magnetic Resonance Spectroscopy 15Irinotecan 14Nivolumab 12Biopsy 12Albumin-Bound Paclitaxel 12tislelizumab 11Specimen Handling 11Radiofrequency Ablation 11Drug Therapy 11pemigatinib 10apatinib 10Taxes 10Floxuridine 10130-nm albumin-bound paclitaxel 10Radiotherapy 9Bevacizumab 9Platinum 8Folfox protocol 8Carboplatin 81,2-diaminocyclohexaneplatinum II citrate 8tremelimumab 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Cholangiocarcinoma × Endoscopy, Digestive System × Clear all
NCT03942328 2026-04-20

Modified Immune Cells (Autologous Dendritic Cells) and a Vaccine (Prevnar) Combined With Immune Checkpoint Inhibition After High-Dose External Beam Radiation Therapy in Treating Patients With Unresectable Liver Cancer

Mayo Clinic

Phase 1/2 Recruiting
85 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Cholangiocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡